De Méo M, Laget M, Di Giorgio C, Guiraud H, Botta A, Castegnaro M, Duménil G
Laboratoire de Biogénotoxicologie et Mutagénèse Environnementale (EA 1784), Faculté de Pharmacie, Marseille, France.
Mutat Res. 1996 Jun;340(2-3):51-65. doi: 10.1016/s0165-1110(96)90039-1.
Assessing urine mutagenicity with the Salmonella mutagenicity test is often limited by the volumes of the samples. Optimization of the assay was performed with factorial and Doehlert designs. Two fractional factorial designs 2(3-1) (3 factors, 4 experiments) were used to estimate the main effects of the percent S9 in the mix, the time of liquid incubation, the inoculum size and the growth conditions. A Doehlert design (3 factors, 13 experiments) was used to study the main effects and the interactions of the NADP, G6P and S9 in the mix. The positive markers were benzo[a]pyrene (BaP, 0.3 microgram/plate) and a pool of smokers' urine (SU, 1.25 ml equivalent/plate). The response was limited to the induction factor (IF, number of induced revertants/number of spontaneous revertants) with Salmonella typhimurium TA98. The optimal conditions for BaP were: a 60 min period of liquid incubation and a volume of 0.1 ml (approx. 10(8) cells/plate) of an overnight culture grown in 50 ml of Nutrient Broth No. 2 from a 250 ml flask. The S9 mix (0.1 ml, final volume) included 1.5% of S9, 1.0 mM NADP and 4.4 mM G6P. The maximal IF was 15.79. The optimal conditions for SU were: a 60 min period of liquid incubation and a volume of 0.1 ml (approx. 10(8) cells/plate) of an overnight culture grown in 7 ml of Nutrient Broth No. 2 from a 20 x 180 mm tube. The S9 mix (0.1 ml, final volume) included: 4% S9, 4.2 mM NADP and 5.2 mM G6P. The maximal IF was 10.95. These optimal conditions did not modify the spontaneous frequencies of the tester strains: TA97a, TA98, TA100 and TA102. The dose-response curves of mutagenic urine samples were found to be non-linear. This micromethod required 8-fold less urine sample and 12.5-fold less liver homogenate as compared to the standard plate incorporation assay and was from 6.2- to 11.8-fold more sensitive to evaluate urine mutagenicity. The sensitivity of this technique was found to be limited to individuals smoking more than approx. 5 cigarettes/day by the standard extraction-concentration procedure.
用沙门氏菌致突变性试验评估尿液致突变性常常受到样品量的限制。采用析因设计和Doehlert设计对该试验进行了优化。使用两个2(3 - 1) 分数析因设计(3个因素,4次实验)来估计混合物中S9的百分比、液体孵育时间、接种量和生长条件的主要效应。采用Doehlert设计(3个因素,13次实验)来研究混合物中NADP、G6P和S9的主要效应及相互作用。阳性标记物为苯并[a]芘(BaP,0.3微克/平板)和吸烟者尿液混合液(SU,1.25毫升当量/平板)。反应以鼠伤寒沙门氏菌TA98的诱导因子(IF,诱导回复突变体数/自发回复突变体数)来衡量。BaP的最佳条件为:液体孵育60分钟,接种量为0.1毫升(约10⁸细胞/平板),该过夜培养物由250毫升烧瓶中50毫升2号营养肉汤培养得到。S9混合物(最终体积0.1毫升)包含1.5%的S9、1.0毫摩尔NADP和4.4毫摩尔G6P。最大IF为15.79。SU的最佳条件为:液体孵育60分钟,接种量为0.1毫升(约10⁸细胞/平板),该过夜培养物由20×180毫米试管中7毫升2号营养肉汤培养得到。S9混合物(最终体积0.1毫升)包含:4% S9、4.2毫摩尔NADP和5.2毫摩尔G6P。最大IF为10.95。这些最佳条件并未改变测试菌株TA97a、TA98、TA100和TA102的自发频率。发现致突变尿液样品的剂量 - 反应曲线呈非线性。与标准平板掺入法相比,这种微量方法所需的尿液样品量减少了8倍,肝脏匀浆减少了12.5倍,评估尿液致突变性的灵敏度提高了6.2至11.8倍。通过标准提取 - 浓缩程序发现,该技术的灵敏度仅限于每天吸烟超过约5支的个体。